← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2013Last known activity
Jan 31, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 3 trials)
Phase 2 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT05697328Lead sponsorN/AJan 31, 2023
- NCT05697328Overall official - principal investigatorN/AJan 31, 2023
- NCT05697328Reponsible party - principal investigatorN/AJan 31, 2023
- NCT02008656CollaboratorPhase 2Nov 1, 2013
- NCT01819272Overall official - principal investigatorPhase 2Apr 1, 2013
Details
- Last known activity
- Jan 31, 2023